RSNA 2014 

Abstract Archives of the RSNA, 2014


SSA18-08

Diuretic FDG PET/CT and Diffusion Weighted MR Imaging for Urothelial Carcinoma: Comparison of SUV, ADC and Pathological Characteristics

Scientific Papers

Presented on November 30, 2014
Presented as part of SSA18: ISP: Nuclear Medicine (PET/CT for Oncology)

Participants

Munenobu Nogami MD, PhD, Presenter: Nothing to Disclose
Hitomi Iwasa MD, Abstract Co-Author: Nothing to Disclose
Shino Kohsaki MD, Abstract Co-Author: Nothing to Disclose
Taiji Tamura, Abstract Co-Author: Nothing to Disclose
Michiko Tadokoro MD, Abstract Co-Author: Nothing to Disclose
Kei Kubota MD, PhD, Abstract Co-Author: Nothing to Disclose
Kazuo Morio, Abstract Co-Author: Nothing to Disclose
Naoki Akagi, Abstract Co-Author: Nothing to Disclose
Akihito Nishioka MD, PhD, Abstract Co-Author: Nothing to Disclose

PURPOSE

By using diuretic, evaluation of urothelial carcinoma is feasible on FDG PET/CT. The purpose was to determine the association between glucose metabolism, restricted diffusion and pathological characteristics of urothelial carcinoma by comparison of FDG PET/CT after diuretic (diuretic PET/CT) and diffusion weighted (DWI) MR imaging. 

METHOD AND MATERIALS

Twenty-two consecutive patients with pathologically confirmed urothelial carcinoma (bladder cancer, n=8; ureteral cancer, n=6; and renal pelvis cancer, n=8) underwent diuretic PET/CT and DWI MRI within one week without any therapy and/ or intervention. Diuretic PET/CT was performed 180 min after administration of FDG and 60 min after furosemide injection, followed by a contrast-enhanced CT. DWI MRI was acquired at 3.0T with b-values of 0 and 1000 sec/mm2. Maximum standardized uptake value (SUVmax) and minimum apparent diffusion coefficient (ADCmin) were measured by placing a region of interest on diuretic PET/CT and DWI MRI, respectively. Pathological results including tumor depth, lymphatic and venous permeation were acquired from all the subjects by operations and biopsies. To determine the relationship between glucose metabolism and restricted diffusion of the tumors, SUVmax and ADCmin were statistically compared by the Spearman’s rank correlation coefficient. To evaluate the correlation between pathological status and glucose metabolism and/ or restricted diffusion, SUVmax and ADCmin were statistically compared with pathological characteristics by the Mann-Whitney test.

RESULTS

The histopathological results showed 16 invasive and 6 non-invasive urothelial carcinomas. Significant inverse correlation was found between SUVmax (13.5 ± 9.8) and ADCmin (1.09 ± 0.51 × 10-3 mm2/s) (r=-0.51, p<0.05). There was no significant correlation of pathological findings with SUVmax and/or ADCmin.

CONCLUSION

In this preliminary study, there was significant correlation between SUVmax and ADCmin, suggesting relationship between glucose metabolism and restricted diffusion of the urothelial carcinoma similar to the other cancers reported by the literatures. Pathological characteristics of the urothelial carcinoma may be determined by the other factors of the tumor.

CLINICAL RELEVANCE/APPLICATION

Diuretic FDG PET/CT yields evaluation of glucose metabolism of urothelial carcinoma and may have incremental role of quantitative evaluation for the patients with urothelial carcinoma.

Cite This Abstract

Nogami, M, Iwasa, H, Kohsaki, S, Tamura, T, Tadokoro, M, Kubota, K, Morio, K, Akagi, N, Nishioka, A, Diuretic FDG PET/CT and Diffusion Weighted MR Imaging for Urothelial Carcinoma: Comparison of SUV, ADC and Pathological Characteristics.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14014937.html